Ads
related to: atopic dermatitis information- Before & After Photos
See the Before and After of What
A Treatment Option Can Do For You.
- Eczema Causes
Learn More About The Causes
Of Eczema (Atopic Dermatitis).
- What Is Eczema?
Find Important Facts & Information
To Understand Atopic Dermatitis.
- Atopic Dermatitis
Learn About Causes, Symptoms,
& An Oral Treatment Option.
- Sign Up for Info
Get Updates, Answers, and Resources
For Treatment Support
- Take Our Symptoms Quiz
Take Our Quiz To Learn
About Your Symptoms.
- Before & After Photos
Search results
Earnings call: Aclaris Therapeutics progresses with atopic dermatitis study By Investing.com
Investing.com· 5 days ago(NASDAQ:ACRS) has announced during its First Quarter 2024 Conference Call that it will advance...
Earnings call: Almirall targets leadership in medical dermatology with Q1 growth By Investing.com
Investing.com· 3 hours agoAlmirall, the pharmaceutical company specializing in medical dermatology, outlined a solid start to...
Systemic antibiotics in first year of life tied to higher atopic dermatitis risk
Medical Xpress· 5 days agoSystemic antibiotic exposure in the first year of life is associated with higher atopic dermatitis...
13 Penny Stocks with Insider Buying in 2024
Insider Monkey via Yahoo Finance· 1 day agoIn this article, we will take a detailed look at the 13 Penny Stocks with Insider Buying in 2024. If you want to skip our detailed analysis and see the...
Nektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoNektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript May 9, 2024 Nektar Therapeutics...
...DX Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During...
Benzinga· 7 days agoThe KOL event, "Treatment Options for Atopic Dermatitis Patients with an Inadequate Response to Dupilumab: Exploring the Potential...
Almirall Delivers Strong Start of 2024 – Q1 Net Sales Growth of 6.6% Overall and 18% in the European...
Benzinga· 21 hours agoPositive trajectory with Net Sales increase by 6.6% to a total of €247.4 MM, EBITDA increase of 1.4% YoY to a total of €52.5 MM driven by higher overall sales Performance driven by biologics as key growth engines,
Nektar Therapeutics Reports First Quarter 2024 Financial Results
Colorado Springs Gazette· 4 days agoNektar Therapeutics (Nasdaq: NKTR) today reported financial results for the first quarter ended March 31, 2024. Cash and investments in marketable securities at March 31, 2024 were $326.0 million ...
Q1 2024 Aclaris Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 days agoPlease be advised that today's call is being recorded and webcast. A link to the webcast can...Today, I'm pleased to announce that we have decided to move ATI 2138 forward any proof of concept ...
BofA bullish on Apogee stock, sees significant market growth potential By Investing.com
Investing.com· 4 days agoFriday, BofA Securities initiated coverage on Apogee (NASDAQ:APOG) Therapeutics Inc (NASDAQ:APGE)...
Ads
related to: atopic dermatitis information
